TITAN PHARMACEUTICALS INC
Biological Products, (No Diagnostic Substances) · 400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080
官方登记数据
0位关注者
2015成立于
关于 TITAN PHARMACEUTICALS INC
Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in San Francisco, CA, developing proprietary therapeutics primarily for treating central nervous system ("CNS") disorders. In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceeds. In the same month, it also posted approximately $1.7 million in revenue, in large part drawn from its licensing for its European intellectual property rights for Probuphine to the Italian pharmaceutical company Molteni – a leading European opioid manufacturer and also a subsidiary of the German Pharmaceutical juggernaut Merck Group.
Source: Wikipedia
行业Biological Products, (No Diagnostic Substances)
总部400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080
成立2015
法律形式C Corporation
状态营业中
专利6 项专利
IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCESJP2025069303A · 2025
LOADABLE POROUS STRUCTURES FOR USE AS IMPLANTSJP2024133539A · 2024
关键数据
法律信息
| 法定名称 | TITAN PHARMACEUTICALS INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 910267在 SEC EDGAR 上查看 ↗ |
| EIN | 94-3171940 |
| 行业代码(SIC) | 2836 |
| 注册地址 | 400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面